South Africa’s authority is placing unreasonable hurdles in the way of desperately ill and dying patients  with drug resistant tuberculosis, stopping them from accessing a new drug that offers their only hope... 

While MSF awaits registration of bedaquiline in South  Africa and therefore  broader access,acesss to this life saving drug for patients with few other treatment options should not be denied without adequate explanation ... 

MSF and other organisation around the world have attempted to use bedaquiline for a select few patients with multidrug-resistant TB(XDR TB).For many of these patients there is no other hope and bedaquiline offers a last chance of survival...